- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Melanie Bella on How CMS is Working to Increase Access of Quality Services for Dual Eligibles
Melanie Bella, director, Medicare-Medicaid Coordination Office, Centers for Medicare & Medicaid Services, says the sole focus of the Medicare-Medicaid Coordination Office is to increase coordination and access to services from many fronts.
Melanie Bella, director, Medicare-Medicaid Coordination Office, Centers for Medicare & Medicaid Services (CMS), says the sole focus of the Medicare-Medicaid Coordination Office is to increase coordination and access to services on many fronts. One way CMS is increasing access for dual eligibles is through the Program Alignment Initiative. It looks at programs and how they do or do not work together for beneficiaries.
“We are very focused on data, which may not sound like a direct benefit to beneficiaries, but getting Medicare data linked with Medicaid data and into the hands of care managers allows us to foster coordination and access for beneficiaries,” said Ms Bella.
CMS is also sponsoring demonstrations that integrate the full spectrum of Medicaid and Medicare services. These provide beneficiary enhancements so that beneficiaries are getting access to all the care they are entitled to under both programs.
ACA Network Regulatory Filings Are Inaccurate, Poorly Match Provider Directories
September 16th 2025A secret shopper survey (N = 8306) in Pennsylvania’s Affordable Care Act (ACA) Marketplace found inconsistencies between carrier regulatory filings and provider directories, frequent inaccuracies in regulatory filings, and challenges in securing timely appointments.
Read More
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
